179 related articles for article (PubMed ID: 36110031)
1. Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer's disease.
Euler MJ; Duff K; King JB; Hoffman JM
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):885-902. PubMed ID: 36110031
[TBL] [Abstract][Full Text] [Related]
2. Recognition subtests for the Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary data in cognitively intact older adults, amnestic Mild Cognitive Impairment, and Alzheimer's disease.
Duff K; Suhrie KR; Dalley BCA; Porter SM; Dixon AM
Clin Neuropsychol; 2021 Nov; 35(8):1415-1425. PubMed ID: 32883179
[No Abstract] [Full Text] [Related]
3. Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer's disease.
Duff K; Suhrie KR; Hammers DB; Dixon AM; King JB; Koppelmans V; Hoffman JM
Clin Neuropsychol; 2023 Jan; 37(1):157-173. PubMed ID: 34713772
[TBL] [Abstract][Full Text] [Related]
4. Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer's Disease using the Repeatable Battery for the Assessment of Neuropsychological Status.
Suhrie KR; Hammers DB; Porter SM; Dixon AM; King JB; Anderson JS; Duff K; Hoffman JM
J Clin Exp Neuropsychol; 2021 Nov; 43(9):861-878. PubMed ID: 35019815
[TBL] [Abstract][Full Text] [Related]
5. Recognition subtests of the Repeatable Battery for the Assessment of Neuropsychological Status: evidence for a cortical vs. subcortical distinction.
Vehar JV; Rahimpour S; Moretti P; Kassavetis P; Alshaikh J; Rolston J; Duff K
J Clin Exp Neuropsychol; 2023 Oct; 45(8):786-797. PubMed ID: 37728425
[TBL] [Abstract][Full Text] [Related]
6. Change on the Repeatable Battery for the Assessment of Neuropsychological Status and its relationship to brain amyloid.
Duff K; Dixon AM; Embree L; Hoffman JM
J Clin Exp Neuropsychol; 2023 Mar; 45(2):105-117. PubMed ID: 37224404
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
Duff K; Hammers DB; Koppelmans V; King JB; Hoffman JM
J Alzheimers Dis; 2024; 99(1):321-332. PubMed ID: 38669544
[TBL] [Abstract][Full Text] [Related]
8. Relationship between
Hammers DB; Atkinson TJ; Dalley BC; Suhrie KR; Beardmore BE; Burrell LD; Horn KP; Rasmussen KM; Foster NL; Duff K; Hoffman JM
Clin Neuropsychol; 2017 Apr; 31(3):531-543. PubMed ID: 28077020
[TBL] [Abstract][Full Text] [Related]
9. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease.
Karantzoulis S; Novitski J; Gold M; Randolph C
Arch Clin Neuropsychol; 2013 Dec; 28(8):837-44. PubMed ID: 23867976
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of memory subtests and learning slopes from the ADAS-Cog to distinguish along the continuum of the NIA-AA Research Framework for Alzheimer's Disease.
Hammers DB; Kostadinova RV; Spencer RJ; Ikanga JN; Unverzagt FW; Risacher SL; Apostolova LG;
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):866-884. PubMed ID: 36074015
[TBL] [Abstract][Full Text] [Related]
11. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.
Papp KV; Rofael H; Veroff AE; Donohue MC; Wang S; Randolph C; Grober E; Brashear HR; Novak G; Ernstrom K; Raman R; Aisen PS; Sperling R; Romano G; Henley D
J Prev Alzheimers Dis; 2022; 9(2):255-261. PubMed ID: 35542998
[TBL] [Abstract][Full Text] [Related]
13. The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
Teng E; Manser PT; Shah M; Pickthorn K; Hu N; Djakovic S; Swendsen H; Blendstrup M; Faccin G; Ostrowitzki S; Sink KM
J Prev Alzheimers Dis; 2023; 10(1):41-49. PubMed ID: 36641609
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
[TBL] [Abstract][Full Text] [Related]
15. Are the indices of the RBANS sufficient for differentiating Alzheimer's disease and subcortical vascular dementia?
McDermott AT; DeFilippis NA
Arch Clin Neuropsychol; 2010 Jun; 25(4):327-34. PubMed ID: 20430863
[TBL] [Abstract][Full Text] [Related]
16. Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
Goldstein FC; Loring DW; Thomas T; Saleh S; Hajjar I
J Alzheimers Dis; 2019; 72(2):507-514. PubMed ID: 31594225
[TBL] [Abstract][Full Text] [Related]
17. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
[TBL] [Abstract][Full Text] [Related]
18. Semantic memory activation in amnestic mild cognitive impairment.
Woodard JL; Seidenberg M; Nielson KA; Antuono P; Guidotti L; Durgerian S; Zhang Q; Lancaster M; Hantke N; Butts A; Rao SM
Brain; 2009 Aug; 132(Pt 8):2068-78. PubMed ID: 19515831
[TBL] [Abstract][Full Text] [Related]
19. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
[TBL] [Abstract][Full Text] [Related]
20. RBANS memory percentage retention: No evidence of incremental validity beyond RBANS scores for diagnostic classification of mild cognitive impairment and dementia and for prediction of daily function.
Jodouin KA; O'Connell ME; Morgan DG
Appl Neuropsychol Adult; 2017; 24(5):420-428. PubMed ID: 27282346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
